Clinical Trial

Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this study is to quantify day-to-day changes in blood glucose during treatment towards remission in ketosis-prone diabetes (KPDM) and describe them using a mathematical model of KPDM pathogenesis and remission.
Protocol Amendment History 3 changes
critical Trial status changed: Active, Not Recruiting → Recruiting 2026-06-16
notable Primary completion pushed: 2026-06 -> 2027-01 2026-06-16
minor Completion pushed: 2026-06 -> 2027-01 2026-06-16
Trial Details
NCT Number NCT06699810
Lead Sponsor Emory University
Conditions Ketosis Prone Diabetes
Enrollment 12 participants
Start Date 2025-01-23
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-15